Researchers at the University of Virginia Health System have identified an important role played by a gene called CASS4 in protecting the brain against harmful protein buildup associated with Alzheimer’s disease.
The discovery could open new research directions for understanding the disease and developing future treatments. The study, published in the Journal explains how this gene helps the brain’s immune system manage harmful protein deposits.
How the CASS4 Gene Protects the Brain
Scientists found that CASS4 helps regulate microglia, specialised immune cells that act as the brain’s natural cleaning and defence system.
These cells surround and contain amyloid-beta plaques, which are associated with Alzheimer’s disease. When CASS4 activity was disrupted, the immune cells became less effective at controlling these deposits.
Experiments Reveal Important Findings
In laboratory experiments involving mice, researchers observed that disrupting the gene led to faster plaque accumulation and damage to nearby nerve cells. The animals also showed worsening cognitive performance.
The findings suggest that CASS4 may play a more important role in the brain’s immune system than scientists previously understood.
Could This Lead to Future Treatments?
Researchers believe that improving CASS4 activity or strengthening microglia could eventually offer a new direction for Alzheimer’s treatment.
However, these results are based on animal experiments. Further research is necessary to establish whether the same mechanism works in humans and whether it can be safely targeted with future treatments.
